testosterone screening

US Defense Secretary Pete Hegseth has mandated annual testosterone-deficiency screening for active-duty and reserve service members aged 30 and older. This initiative, integrated into existing periodic health assessments, aims to enhance military readiness by optimizing the natural capabilities of troops. Hegseth stated the program is about restoring and optimizing these capabilities. However, the plan has drawn skepticism from medical professionals who question the evidence supporting its effectiveness. Concerns have been raised that the screening and potential subsequent prescription of testosterone could inadvertently increase service members' risk of infertility or other adverse health consequences. The new policy is currently newsworthy due to its recent announcement and the ongoing debate surrounding its medical justification and potential impact on troop health.